MedTrace Logo

Fractional Exhaled Nitric Oxide as Possible Non - Invasive Biomarker to Assess Obstructive Sleep Apnea Severity

NCT07606898 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-05-26

No results posted yet for this study

Summary

Aim of work

1. Primary aim: Asses correlation between FeNO level, OSA severity
2. Secondary aim: Clarifying FeNO's role as a biomarker to assess airway inflammation, Cut off value prediction to moderate and severe OSA and its potential significance to improve clinical management strategies for OSA patients.

Conditions

  • Obstructive Sleep Apnea (OSA)

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Mohammed Sayed Hantira, professor · Tanta University

  • Ayman Hassan AbdElzaher, professor · Tanta University

  • Ahmed Gharib Gharib, assistant professor · cairo institute for research

  • Mohammed Samy Torky, assistant professor · Tanta University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2026-09-30
Completion
2026-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07606898 on ClinicalTrials.gov